Diagenode D-Plex Small RNA DNBSEQ Kit
Diagenode has launched the D-Plex Small RNA DNBSEQ Kit, a small RNA sequencing product specifically formatted for MGI's DNBSEQ sequencers. The kit is based on a tailing and template switching technology that delivers a ligation-free method for RNA library preparation from small RNA input amounts as low as 10 picograms. The technology also enables detection of diverse and novel transcripts, ensuring realistic representation of the small non-coding RNA transcriptome and avoiding biased miRNA enrichment as with ligation methods, the company said. Furthermore, the kit has been validated for liquid biopsy applications, Diagenode said. The kit is available in a 24-reaction format with two sets of DNBSEQ barcodes available.
Analytical BioSciences OmniBrowser
Analytical BioSciences has launched OmniBrowser, a curated web portal for single-cell RNA-seq data visualization and analysis for drug discovery and development. OmniBrowser was designed specifically to support biologists with limited programming experience, and its underlying curated database features more than 1,490 datasets, 680 studies, 18,000 clusters, and 21 million cells, and is constantly updated, the company said. The platform provides web-based tools for dataset selection; dimensional reduction; differential gene expression; correlation analysis; marker gene information; Gene Ontology analysis; supervised annotation; and metadata analysis. OmniBrowser also provides multiple large-scale data-processing functions including gene search and cell ontology, the company said.
Eurofins Genomics SARS-CoV-2 NGS Service, ARTIC Oligo Mix
Eurofins Genomics has launched a SARS-CoV-2 next-generation sequencing service providing full-length viral genome sequences, and will shortly launch its ARTIC NGS oligo mix. The service and oligo mix are based on a protocol by the ARTIC consortium, which is used for SARS-CoV-2 sequencing worldwide. The ARTIC approach utilizes an oligo pool for multiplexed PCR amplification of the complete viral genome. Eurofins Genomics said that it optimized the formulation of the oligo pool for highest performance and uniformity of coverage for the full-length viral genome. Eurofins is offering part of its sequencing capacity for free to public healthcare authorities who do not have emergency budgets available to detect the VUI2020-12/01 strain reported to be currently fast-spreading in the UK.
For more new products and services, please visit the New Products page on our website.